Painkillers for rheumatoid arthritis

Photo of a man taking his medicine

Anti-inflammatory painkillers and steroids can relieve the symptoms of rheumatoid arthritis. But they don't prevent joint damage. They are suitable for the relief of acute pain, as a temporary treatment until disease-modifying drugs start to work.

Certain medications can reduce inflammation in the body, which prevents joint damage and relieves pain. These drugs are called disease-modifying antirheumatic drugs (DMARDs). But it can take several weeks before they start working. Until that happens, the symptoms of rheumatoid arthritis can be relieved with painkillers and steroids.

Which painkillers are effective in relieving joint pain?

Non-steroidal (NSAIDs) are painkillers that can relieve pain in the joints. These drugs include:

  • Celecoxib
  • Diclofenac
  • Etoricoxib
  • Ibuprofen
  • Naproxen

Research has found that they relieve symptoms in about 15 out of 100 people.

What are the possible side effects of non-steroidal anti-inflammatory drugs?

The possible side effects of anti-inflammatory painkillers include:

  • An upset stomach: in about 3 out of 100 people.
  • Ulcers and bleeding in the stomach: in up to 2 out of 100 people who regularly take NSAIDs for a year.
  • Cardiovascular (heart and blood vessel) disease: in up to 1 out of 100 people who regularly take NSAIDs for a year.

The risk of side effects and complications will depend on various factors, such as the exact medication and dose. Celecoxib and etoricoxib are less likely to cause stomach problems than other NSAIDs are, for example.

These NSAIDs can somewhat increase the risk of cardiovascular diseases such as heart attacks. Naproxen has the lowest risk of all NSAIDs, so it is the most suitable for people who have both rheumatoid arthritis and a cardiovascular disease.

When used over the long term, NSAIDs can lead to stomach ulcers. These are usually felt as a pain in the upper abdomen. The pain is particularly noticeable just after eating, when the stomach produces more acid. Sometimes stomach ulcers don't cause any symptoms, and people only find out that they have one if they have serious complications such as bleeding in the stomach.

Who has a higher risk of complications?

Stomach ulcers or bleeding are more likely to occur in people who

  • are over 65 years old,
  • have other serious diseases, especially gastrointestinal conditions like or ,
  • have already had gastritis (an of the stomach), a stomach or stomach bleeding,
  • have an with Helicobacter pylori ,
  • drink a lot of alcohol,
  • take blood-thinning heart medicines, for example anticoagulants like warfarin or acetylsalicylic acid,
  • take a selective serotonin reuptake inhibitor (SSRI) antidepressant,
  • take corticosteroids (“steroids”), or
  • take several anti-inflammatory painkillers at the same time.

NSAIDs can sometimes permanently worsen the functioning of the kidney in people who have kidney disease too.

How can side effects be avoided?

NSAIDs should only be used when needed, and not over a long period of time – in other words, only to relieve acute pain. It is important to use the lowest dose possible, and not to exceed the maximum daily dose. If you're considering using NSAIDs, it's best to talk to your doctor about the most suitable medication and dose.

The risk of complications affecting the gastrointestinal tract can be lowered considerably by taking NSAIDs together with medicine designed to protect the lining of the stomach. These include, in particular, proton pump inhibitors like omeprazole or pantoprazole.

Alternatively, diclofenac or ibuprofen can be applied to the painful joint in the form of a cream or gel. The risk of side effects is then much lower than it is if you take tablets.

Does acetaminophen (paracetamol) help in rheumatoid arthritis?

The painkiller acetaminophen (paracetamol) only has a weak anti-inflammatory effect. Research has shown that it hardly helps people with rheumatoid arthritis, and clearly relieves the pain less effectively than NSAIDs do.

If you take acetaminophen anyway, it's important to use it correctly. Higher doses can lead to liver and kidney damage. So adults shouldn't take more than 4 grams (4,000 milligrams) per day according to the package insert. This is the amount in, for example, 8 tablets containing 500 milligrams (mg) of acetaminophen each. Waiting at least six hours between two doses is also recommended. So two 500 mg tablets of acetaminophen every six hours over one day would be the maximum allowed amount.

When does it make sense to use steroids?

Steroid medications (glucocorticoids) such as prednisolone help to reduce pain and swelling in the affected joints. They start working fast and have a stronger effect than NSAIDs do. They can help to cover the stretch of time until the basic therapy with disease-modifying drugs starts working. They can also be used for the temporary treatment of rheumatoid arthritis flare-ups. But experts recommend not using steroids for more than three to six months. One reason for this is because the medication might become less effective over time.

Steroids can also have a number of serious side effects when taken over longer periods of time. These include an increased risk of infections. People who have osteoporosis can combine steroids with things like and vitamin D supplements to help prevent bone fractures.

If treatment with steroids is stopped too suddenly, the symptoms might actually get worse. So it’s important to gradually reduce the dose instead.

Steroids can be injected directly into individual joints to target the worst affected joints. This reduces the risk of side effects that affect the whole body. But local side effects, such as an in the joint, are still possible. Unfortunately there’s a lack of good-quality research on the advantages and disadvantages of these steroid injections.

Bergstra SA, Sepriano A, Kerschbaumer A et al. Efficacy, duration of use and safety of glucocorticoids: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis. Ann Rheum Dis 2023; 82(1): 81-94.

Bhala N, Emberson J, Merhi A et al. Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet 2013; 382(9894): 769-779.

Da Costa BR, Reichenbach S, Keller N et al. Effectiveness of non-steroidal anti-inflammatory drugs for the treatment of pain in knee and hip osteoarthritis: a network meta-analysis. Lancet 2017; 390(10090): e21-e33.

Dachverband der Deutschsprachigen Wissenschaftlichen Osteologischen Gesellschaft (DVO). Prophylaxe, Diagnostik und Therapie der Osteoporose bei postmenopausalen Frauen und bei Männern (Leitlinie in Überarbeitung). AWMF-Registernr.: 183-001. 2017.

Derry S, Conaghan P, Da Silva JA et al. Topical NSAIDs for chronic musculoskeletal pain in adults. Cochrane Database Syst Rev 2016; (4): CD007400.

Deutsche Gesellschaft für Rheumatologie (DGRh). Management der frühen rheumatoiden Arthritis (S3-Leitlinie). AWMF-Registernr.: 060-002. 2019.

Fidahic M, Jelicic Kadic A, Radic M et al. Celecoxib for rheumatoid arthritis. Cochrane Database Syst Rev 2017; (6): CD012095.

Hazlewood G, van der Heijde DM, Bombardier C. Paracetamol for the management of pain in inflammatory arthritis: a systematic literature review. J Rheumatol Suppl 2012; 90: 11-16.

McWilliams DF, Thankaraj D, Jones-Diette J et al. The efficacy of systemic glucocorticosteroids for pain in rheumatoid arthritis: a systematic literature review and meta-analysis. Rheumatology (Oxford) 2021; 61(1): 76-89.

Ofman JJ, Maclean CH, Straus WL et al. Meta-analysis of dyspepsia and nonsteroidal antiinflammatory drugs. Arthritis Rheum 2003; 49(4): 508-518.

Rostom A, Dube C, Wells G et al. Prevention of NSAID-induced gastroduodenal ulcers. Cochrane Database Syst Rev 2002; (4): CD002296.

Van Walsem A, Pandhi S, Nixon RM et al. Relative benefit-risk comparing diclofenac to other traditional non-steroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors in patients with osteoarthritis or rheumatoid arthritis: a network meta-analysis. Arthritis Res Ther 2015; 17: 66.

IQWiG health information is written with the aim of helping people understand the advantages and disadvantages of the main treatment options and health care services.

Because IQWiG is a German institute, some of the information provided here is specific to the German health care system. The suitability of any of the described options in an individual case can be determined by talking to a doctor. can provide support for talks with doctors and other medical professionals, but cannot replace them. We do not offer individual consultations.

Our information is based on the results of good-quality studies. It is written by a team of health care professionals, scientists and editors, and reviewed by external experts. You can find a detailed description of how our health information is produced and updated in our methods.

Comment on this page

What would you like to share with us?

We welcome any feedback and ideas - either via our form or by We will review, but not publish, your ratings and comments. Your information will of course be treated confidentially. Fields marked with an asterisk (*) are required fields.

Please note that we do not provide individual advice on matters of health. You can read about where to find help and support in Germany in our information “How can I find self-help groups and information centers?

Über diese Seite

Updated on January 11, 2024

Next planned update: 2027


Institute for Quality and Efficiency in Health Care (IQWiG, Germany)

How we keep you informed

Follow us on Twitter or subscribe to our newsletter or newsfeed. You can find all of our films online on YouTube.